WALL STREET STOCKSMARION LABS ltMKC Marion Laboratories Incs stock rose sharply today company presented bullish earnings scenario meeting pharmaceutical analysts Monday traders analysts said company expects earnings fiscal 1987 ending June 30 rise 75 pct year ago pronouncement encouraged analyst David Crossen Sanford C Bernstein raise earnings estimates company 128 dlrs share 1987 compared previous estimate 120 dlrs share year company earned 70 cts share Marions stock gained 314 7512 meeting pharmaceutical analysts Marions president Fred Lyons Jr Wall Street eanrings estimates 110115 dlrs share fiscal 1987 are expected aggressive side range 10 15 cts low Lyons strong performance half year result fourth quarter introduction 90 mg 120 mg Cardizem tablets Analyst Crossen Cardizem treats angina expected approved treatment hypertension end year Crossen because Marion small company growth Cardizem big impact bottom line raised fiscal 1988 earnings estimates 215 dlrs share previous estimate 205 dlrs share The company broad product pipeline industry concerned innovative company business said years 1991 Crossen expects Marion growth rate 55 pct